Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
06-06

DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 2.30% to $2.12 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.83% to 19,298.45 and Dow Jones Industrial Average falling 0.25% to 42,319.74.

The stock's fall snapped a three-day winning streak.

Inovio Pharmaceuticals Inc. closed 82.81% below its 52-week high of $12.33, which the company reached on July 26th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $153.66, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 1.15% to $23.12.

Trading volume (687,153) eclipsed its 50-day average volume of 614,927.

Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 05, 2025 17:29 ET (21:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10